Valuation: Peptron, Inc.

Market Cap 2,005B 1.49B 1.36B 1.25B 1.14B 2.14B 138B 2.25B 15.27B 6.07B 75.6B 5.61B 5.49B 237B P/E 2024
-96x
P/E 2025 -427x
Enterprise Value 1,928B 1.44B 1.31B 1.21B 1.1B 2.06B 133B 2.16B 14.68B 5.83B 72.68B 5.39B 5.28B 228B EV / Sales 2024
716x
EV / Sales 2025 1,037x
Free-Float
91.5%
Yield 2024 *
-
Yield 2025 -
1 day-2.82%
1 week-7.23%
Current month-6.83%
1 month-15.02%
3 months-53.74%
6 months-63.25%
Current year-66.14%
1 week 83,200
Extreme 83200
94,500
1 month 83,200
Extreme 83200
110,700
Current year 79,200
Extreme 79200
359,000
1 year 79,200
Extreme 79200
369,500
3 years 21,100
Extreme 21100
392,500
5 years 7,050
Extreme 7050
392,500
10 years 7,050
Extreme 7050
392,500
Manager TitleAgeSince
Chief Executive Officer 65 30/03/2021
Chief Executive Officer 60 21/11/1997
Director of Finance/CFO 60 -
Director TitleAgeSince
Director/Board Member 60 31/03/2015
Director/Board Member 60 01/07/1999
Director/Board Member 65 30/03/2021
Date Insider Type Main position Quantity % Market Cap. Importance
11/27/24 A Exercice

Chief Executive Officer

111,462 0.4799%
11/27/24 A Exercice

Chief Financial Officer

8,709 0.0375%
11/27/24 A Exercice

Chief Financial Officer

8,545 0.0368%
Change 5-day change 1-year change 3-year change Capi.($)
-2.82%-7.23%-77.72%+164.62% 1.49B
-2.49%-3.76%+50.31%+62.10% 63.66B
-0.63%-2.91%+6.20%+89.22% 58.56B
-2.37%-2.22%+22.87%+82.31% 54.19B
-2.19%-6.15%+11.92%+108.08% 44.66B
-1.89%-7.28%+13.22%+19.74% 40.51B
-0.93%-0.47%+19.73%+43.75% 36.27B
+1.11%-6.44%+130.68%+641.83% 34.89B
-0.80%+0.61%+77.26%+56.26% 32.26B
-2.17%+16.65%-29.21%+474.05% 31.01B
Average -1.52%-1.38%+22.53%+174.19% 40B
Weighted average by Cap. -1.49%-1.86%+31.75%+150.95%

Financials

2024 2025
Net sales 3.15B 2.35M 2.14M 1.97M 1.79M 3.37M 218M 3.54M 24M 9.54M 119M 8.82M 8.63M 373M 5.63B 4.2M 3.83M 3.53M 3.21M 6.02M 389M 6.32M 42.9M 17.05M 212M 15.76M 15.43M 667M
Net income -22.03B -16.42M -14.96M -13.78M -12.54M -23.52M -1.52B -24.72M -168M -66.68M -831M -61.62M -60.32M -2.61B -13.82B -10.3M -9.39M -8.65M -7.87M -14.76M -954M -15.51M -105M -41.83M -521M -38.66M -37.85M -1.64B
Net Debt -115B -85.47M -77.85M -71.73M -65.25M -122M -7.91B -129M -873M -347M -4.32B -321M -314M -13.57B -77.36B -57.67M -52.52M -48.4M -44.02M -82.59M -5.34B -86.8M -589M -234M -2.92B -216M -212M -9.15B
Projected Income Statement - Annual - Peptron, Inc.
Logo Peptron, Inc.
Peptron Inc is a Korea-based company principally engaged in the development, manufacture and distribution of sustained-release medications. The Company mainly develops the sustained-release medications and produces peptides as drug materials mainly for prostate cancer, hyperpituitarism, diabetes and neurodegenerative disorders. The Company also provides peptide synthesis services and manufactures raw material medicines. The Company distributes its products within domestic market and to overseas markets.
Employees
-
Date Price Change Volume
20/11/26 ₩86,000.00 -2.82% 116,794
19/11/26 ₩88,500.00 +5.23% 123,096
18/11/26 ₩84,100.00 -5.72% 209,966
17/11/26 ₩89,200.00 +0.79% 109,724
16/11/26 ₩88,500.00 -4.53% 123,561
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A087010 Stock